Home

Danny L. Dearen

CIK 1756438 · President & CFO · last filed 2026-05-26

Danny L. Dearen is a President & CFO who has filed 40 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing, for BBNX, was dated May 26, 2026. Across all open-market trades the lifetime net is −$35.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $587.7K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$587.7K

Companies

3

Total Filings

40

Lifetime Open-Market Net

-$35.23M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BBNX Director 32,209 $15.90 $512.1K $0 3 2026-05-26
NSPR Director 102,047 $0.74 $75.6K $0 1 2026-01-16
Axonics, Inc. (AXNX) Delisted President & CFO 23,777 $70.98 $1.69M -$35.23M 35 2023-10-03

Recent Filings

40 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-05-26 BBNX Grant (A) +16,965 $0 EDGAR
2026-01-16 NSPR Grant (A) +44,030 $0 EDGAR
2026-01-14 BBNX Grant (A) +3,997 $0 EDGAR
2025-03-18 BBNX Grant (A) +11,247 $0 EDGAR
2023-10-03 Axonics, Inc. (AXNX) Delisted Mixed +3,575 -$436.5K EDGAR
2023-10-03 Axonics, Inc. (AXNX) Delisted Mixed +18,235 -$901.5K EDGAR
2023-05-31 Axonics, Inc. (AXNX) Delisted Sell (S) −7,999 -$395.6K EDGAR
2023-04-25 Axonics, Inc. (AXNX) Delisted Mixed −6,792 -$1.02M EDGAR
2023-04-24 Axonics, Inc. (AXNX) Delisted Mixed — -$91.7K EDGAR
2023-04-20 — Notice (144) −30,000 -$1.80M EDGAR
Showing 1–10 of 40
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.